APO RESEARCH · REPORT
Medical Second Opinion
Medical Second Opinion Service is the additional consultation taken by the patient after the primary diagnosis. The patient can opt for a medical second opinion if the patient feels dissatisfied with the diagnosis or if there is a need for further validation in case of some serious surgical procedures. There has been an upward surge in medical second opinion services mainly due to financial, health and legal costs involved in the treatment. The increased need for improved diagnosis and treatment planning, reducing the financial cost, and ease of interaction is expected to propel the market growth in the forecast period.
Product & engineering
Understand the product.
Medical Second Opinion Service is the additional consultation taken by the patient after the primary diagnosis. The patient can opt for a medical second opinion if the patient feels dissatisfied with the diagnosis or if there is a need for further validation in case of some serious surgical procedures. There has been an upward surge in medical second opinion services mainly due to financial, health and legal costs involved in the treatment. The increased need for improved diagnosis and treatment planning, reducing the financial cost, and ease of interaction is expected to propel the market growth in the forecast period.
Selected research
Industry Research
Medical Second Opinion Industry Research Report 2026
Market perspective
Medical Second Opinion Service is the additional consultation taken by the patient after the primary diagnosis. The patient can opt for a medical second opinion if the patient feels dissatisfied with the diagnosis or if there is a need for further validation in case of some serious surgical procedures. There has been an upward surge in medical second opinion services mainly due to financial, health and legal costs involved in the treatment. The increased need for improved diagnosis and treatment planning, reducing the financial cost, and ease of interaction is expected to propel the market growth in the forecast period.
The major players in global Medical Second Opinion market include HCA Hospitals, AXA PPP Healthcare, Royal London Group, etc. The top 3 players occupy about 20% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. Hospitals is the main type, with a share about 45%. Cancer is the main application, which holds a share about 25%.
Report Scope
Read the full market overview
This report quantifies the global Medical Second Opinion market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Medical Second Opinion.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Medical Second Opinion Market by Company
HCA Hospitals
AXA PPP Healthcare
Royal London Group
Helsana Group
Cleveland Clinic
Amradnet
Best Doctors Inc
Inova Care
Toranomon Hospital
Keio University Hospital
Johns Hopkins Medicine
Penn Medicine
Oncology International Pvt. Ltd.
GrandOpinion
London Pain Clinic
Mondial Assistance
Medisense
Medo Asia Sdn. Bhd.
Medical Second Opinion Segment by Type
Hospitals
Medical Second Opinion Providing Companies
Health Insurance Companies
Medical Second Opinion Segment by Application
Cancer
Diabetes
Cardiac Disorders
Neurological Disorders
Ocular Disorders
Others
Medical Second Opinion Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Second Opinion market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Second Opinion and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Second Opinion.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Medical Second Opinion companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hospitals
- Medical Second Opinion Providing Companies
- Health Insurance Companies
Applications
- Cancer
- Diabetes
- Cardiac Disorders
- Neurological Disorders
- Ocular Disorders
- Others
Companies covered
- HCA Hospitals
- AXA PPP Healthcare
- Royal London Group
- Helsana Group
- Cleveland Clinic
- Amradnet
- Best Doctors Inc
- Inova Care
- Toranomon Hospital
- Keio University Hospital
- Johns Hopkins Medicine
- Penn Medicine
- Oncology International Pvt. Ltd.
- GrandOpinion
- London Pain Clinic
- Mondial Assistance
- Medisense
- Medo Asia Sdn. Bhd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Medical Second Opinion by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Hospitals
- 2.2.3 Medical Second Opinion Providing Companies
- 2.2.4 Health Insurance Companies
- 2.3 Medical Second Opinion by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Cancer
- 2.3.3 Diabetes
- 2.3.4 Cardiac Disorders
- 2.3.5 Neurological Disorders
- 2.3.6 Ocular Disorders
- 2.3.7 Others
- 2.4 Assumptions and Limitations
3 Medical Second Opinion Breakdown Data by Type
- 3.1 Global Medical Second Opinion Historic Market Size by Type (2021-2026)
- 3.2 Global Medical Second Opinion Forecasted Market Size by Type (2027-2032)
4 Medical Second Opinion Breakdown Data by Application
- 4.1 Global Medical Second Opinion Historic Market Size by Application (2021-2026)
- 4.2 Global Medical Second Opinion Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Medical Second Opinion Market Perspective (2021-2032)
- 5.2 Global Medical Second Opinion Growth Trends by Region
- 5.2.1 Global Medical Second Opinion Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Medical Second Opinion Historic Market Size by Region (2021-2026)
- 5.2.3 Medical Second Opinion Forecasted Market Size by Region (2027-2032)
- 5.3 Medical Second Opinion Market Dynamics
- 5.3.1 Medical Second Opinion Industry Trends
- 5.3.2 Medical Second Opinion Market Drivers
- 5.3.3 Medical Second Opinion Market Challenges
- 5.3.4 Medical Second Opinion Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Medical Second Opinion Players by Revenue
- 6.1.1 Global Top Medical Second Opinion Players by Revenue (2021-2026)
- 6.1.2 Global Medical Second Opinion Revenue Market Share by Players (2021-2026)
- 6.2 Global Medical Second Opinion Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Medical Second Opinion Head Office and Area Served
- 6.4 Global Medical Second Opinion Players, Product Type & Application
- 6.5 Global Medical Second Opinion Manufacturers Established Date
- 6.6 Global Medical Second Opinion Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Medical Second Opinion Market Size (2021-2032)
- 7.2 North America Medical Second Opinion Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Medical Second Opinion Market Size by Country (2021-2026)
- 7.4 North America Medical Second Opinion Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Medical Second Opinion Market Size (2021-2032)
- 8.2 Europe Medical Second Opinion Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Medical Second Opinion Market Size by Country (2021-2026)
- 8.4 Europe Medical Second Opinion Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Medical Second Opinion Market Size (2021-2032)
- 9.2 Asia-Pacific Medical Second Opinion Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Medical Second Opinion Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Medical Second Opinion Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Medical Second Opinion Market Size (2021-2032)
- 10.2 South America Medical Second Opinion Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Medical Second Opinion Market Size by Country (2021-2026)
- 10.4 South America Medical Second Opinion Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Medical Second Opinion Market Size (2021-2032)
- 11.2 Middle East & Africa Medical Second Opinion Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Medical Second Opinion Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Medical Second Opinion Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 HCA Hospitals
- 12.1.1 HCA Hospitals Company Information
- 12.1.2 HCA Hospitals Business Overview
- 12.1.3 HCA Hospitals Revenue in Medical Second Opinion Business (2021-2026)
- 12.1.4 HCA Hospitals Medical Second Opinion Product Portfolio
- 12.1.5 HCA Hospitals Recent Developments
- 12.2 AXA PPP Healthcare
- 12.2.1 AXA PPP Healthcare Company Information
- 12.2.2 AXA PPP Healthcare Business Overview
- 12.2.3 AXA PPP Healthcare Revenue in Medical Second Opinion Business (2021-2026)
- 12.2.4 AXA PPP Healthcare Medical Second Opinion Product Portfolio
- 12.2.5 AXA PPP Healthcare Recent Developments
- 12.3 Royal London Group
- 12.3.1 Royal London Group Company Information
- 12.3.2 Royal London Group Business Overview
- 12.3.3 Royal London Group Revenue in Medical Second Opinion Business (2021-2026)
- 12.3.4 Royal London Group Medical Second Opinion Product Portfolio
- 12.3.5 Royal London Group Recent Developments
- 12.4 Helsana Group
- 12.4.1 Helsana Group Company Information
- 12.4.2 Helsana Group Business Overview
- 12.4.3 Helsana Group Revenue in Medical Second Opinion Business (2021-2026)
- 12.4.4 Helsana Group Medical Second Opinion Product Portfolio
- 12.4.5 Helsana Group Recent Developments
- 12.5 Cleveland Clinic
- 12.5.1 Cleveland Clinic Company Information
- 12.5.2 Cleveland Clinic Business Overview
- 12.5.3 Cleveland Clinic Revenue in Medical Second Opinion Business (2021-2026)
- 12.5.4 Cleveland Clinic Medical Second Opinion Product Portfolio
- 12.5.5 Cleveland Clinic Recent Developments
- 12.6 Amradnet
- 12.6.1 Amradnet Company Information
- 12.6.2 Amradnet Business Overview
- 12.6.3 Amradnet Revenue in Medical Second Opinion Business (2021-2026)
- 12.6.4 Amradnet Medical Second Opinion Product Portfolio
- 12.6.5 Amradnet Recent Developments
- 12.7 Best Doctors Inc
- 12.7.1 Best Doctors Inc Company Information
- 12.7.2 Best Doctors Inc Business Overview
- 12.7.3 Best Doctors Inc Revenue in Medical Second Opinion Business (2021-2026)
- 12.7.4 Best Doctors Inc Medical Second Opinion Product Portfolio
- 12.7.5 Best Doctors Inc Recent Developments
- 12.8 Inova Care
- 12.8.1 Inova Care Company Information
- 12.8.2 Inova Care Business Overview
- 12.8.3 Inova Care Revenue in Medical Second Opinion Business (2021-2026)
- 12.8.4 Inova Care Medical Second Opinion Product Portfolio
- 12.8.5 Inova Care Recent Developments
- 12.9 Toranomon Hospital
- 12.9.1 Toranomon Hospital Company Information
- 12.9.2 Toranomon Hospital Business Overview
- 12.9.3 Toranomon Hospital Revenue in Medical Second Opinion Business (2021-2026)
- 12.9.4 Toranomon Hospital Medical Second Opinion Product Portfolio
- 12.9.5 Toranomon Hospital Recent Developments
- 12.10 Keio University Hospital
- 12.10.1 Keio University Hospital Company Information
- 12.10.2 Keio University Hospital Business Overview
- 12.10.3 Keio University Hospital Revenue in Medical Second Opinion Business (2021-2026)
- 12.10.4 Keio University Hospital Medical Second Opinion Product Portfolio
- 12.10.5 Keio University Hospital Recent Developments
- 12.11 Johns Hopkins Medicine
- 12.11.1 Johns Hopkins Medicine Company Information
- 12.11.2 Johns Hopkins Medicine Business Overview
- 12.11.3 Johns Hopkins Medicine Revenue in Medical Second Opinion Business (2021-2026)
- 12.11.4 Johns Hopkins Medicine Medical Second Opinion Product Portfolio
- 12.11.5 Johns Hopkins Medicine Recent Developments
- 12.12 Penn Medicine
- 12.12.1 Penn Medicine Company Information
- 12.12.2 Penn Medicine Business Overview
- 12.12.3 Penn Medicine Revenue in Medical Second Opinion Business (2021-2026)
- 12.12.4 Penn Medicine Medical Second Opinion Product Portfolio
- 12.12.5 Penn Medicine Recent Developments
- 12.13 Oncology International Pvt. Ltd.
- 12.13.1 Oncology International Pvt. Ltd. Company Information
- 12.13.2 Oncology International Pvt. Ltd. Business Overview
- 12.13.3 Oncology International Pvt. Ltd. Revenue in Medical Second Opinion Business (2021-2026)
- 12.13.4 Oncology International Pvt. Ltd. Medical Second Opinion Product Portfolio
- 12.13.5 Oncology International Pvt. Ltd. Recent Developments
- 12.14 GrandOpinion
- 12.14.1 GrandOpinion Company Information
- 12.14.2 GrandOpinion Business Overview
- 12.14.3 GrandOpinion Revenue in Medical Second Opinion Business (2021-2026)
- 12.14.4 GrandOpinion Medical Second Opinion Product Portfolio
- 12.14.5 GrandOpinion Recent Developments
- 12.15 London Pain Clinic
- 12.15.1 London Pain Clinic Company Information
- 12.15.2 London Pain Clinic Business Overview
- 12.15.3 London Pain Clinic Revenue in Medical Second Opinion Business (2021-2026)
- 12.15.4 London Pain Clinic Medical Second Opinion Product Portfolio
- 12.15.5 London Pain Clinic Recent Developments
- 12.16 Mondial Assistance
- 12.16.1 Mondial Assistance Company Information
- 12.16.2 Mondial Assistance Business Overview
- 12.16.3 Mondial Assistance Revenue in Medical Second Opinion Business (2021-2026)
- 12.16.4 Mondial Assistance Medical Second Opinion Product Portfolio
- 12.16.5 Mondial Assistance Recent Developments
- 12.17 Medisense
- 12.17.1 Medisense Company Information
- 12.17.2 Medisense Business Overview
- 12.17.3 Medisense Revenue in Medical Second Opinion Business (2021-2026)
- 12.17.4 Medisense Medical Second Opinion Product Portfolio
- 12.17.5 Medisense Recent Developments
- 12.18 Medo Asia Sdn. Bhd.
- 12.18.1 Medo Asia Sdn. Bhd. Company Information
- 12.18.2 Medo Asia Sdn. Bhd. Business Overview
- 12.18.3 Medo Asia Sdn. Bhd. Revenue in Medical Second Opinion Business (2021-2026)
- 12.18.4 Medo Asia Sdn. Bhd. Medical Second Opinion Product Portfolio
- 12.18.5 Medo Asia Sdn. Bhd. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst